At a glance
Type: Incretin GLP-1 agonist peptide
Category: Metabolic & incretin research
Alternate names: GLP-1 receptor agonist peptide, NN9535
Historical context
Semaglutide entered clinical development as a long-acting GLP-1 agonist. Pharmaceutical finished products are regulated medicines; VaultLabs supplies laboratory reference material only.
Active research areas
GLP-1 receptor binding and signalling assays
Comparative incretin peptide analytics
Stability and method development for acylated GLP-1 analogs
Material availability
VaultLabs catalog SKUs: semaglutide-30mg — view product pages for current AED pricing and lot documentation.
COA verification available per batch when published to the documentation portal.
Name collision note
Do not confuse Semaglutide with Semax in procurement or search.